Fig. 1

Histopathological characteristics of C1RL in glioma. a. C1RL expression in primary GBM (p-GBM) and nontumour brain tissues in TCGAmic. C1RL expression in distinct WHO grades of glioma in CGGAseq (b), CGGAmic (c), and GSE16011mic (d). C1RL expression in distinct histological types of glioma in TCGAseq (e), CGGAseq (f), CGGAmic (g), and GSE16011mic (h). C1RL expression in four GBM subtypes in TCGAmic (i), TCGAseq (j), CGGAseq (k), and CGGAmic (l). C1RL expression in samples with different GBM statuses in CGGAseq (m) and CGGAmic (n). C1RL expression in IDH1-mutant or IDH1-wild-type LGG or GBM in TCGAmic (o), CGGAseq (p), and CGGAmic (q). O, oligodendroglioma; AO, anaplastic oligodendroglioma; OA, oligoastrocytoma; AOA, anaplastic oligoastrocytoma; A, astrocytoma; AA, anaplastic astrocytoma. Mut, mutant; wt, wild-type. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001